文献速递间质性肺疾病哮喘肺结节与肺癌

未折叠蛋白在肺部疾病中的作用

Role of unfolded proteins in lung disease.
PubMed 文献 · Thorax · 2020-10-19

综述阐述内质网应激与未折叠蛋白反应(UPR)在肺病中的作用:环境毒素、病原体及缺氧均可触发内质网应激,UPR 先代偿后促细胞死亡。UPR 参与肺纤维化、阻塞性肺病(尤其哮喘)、肺部感染和肺癌的发病与进展,但情境特异性机制尚不完整,UPR 正成为潜在治疗靶点。

要点

  • 环境毒素、病原体和缺氧均可触发内质网应激并激活 UPR。
  • UPR 短暂抑制蛋白合成并增强折叠与降解,持续应激则激活细胞死亡。
  • UPR 与肺纤维化、哮喘、肺部感染和肺癌相关,但机制尚未完全阐明。

核心结论

  • UPR 防御内质网应激并影响多种呼吸疾病,正成为治疗干预的潜在靶点。
  • UPR 异常激活可能与疾病发病和进展相关,但情境与疾病特异性机制尚不完整。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 环境毒素(包括吸烟、空气污染、石棉)、病原体(细菌、病毒和真菌)及局部或全身缺氧均可触发内质网应激。
  • 内质网腔内错误折叠蛋白蓄积激活 UPR,UPR 效应物短暂减少蛋白合成、增强错误折叠蛋白降解并提高内质网折叠能力。
  • 内质网应激成功代偿则恢复稳态与蛋白合成,持续存在则激活细胞死亡通路。
  • UPR 在多种呼吸疾病患者气道及相应实验模型中被触发,内质网应激与肺纤维化起始和进展相关。
  • 证据累积提示内质网应激见于阻塞性肺病(尤其哮喘)、肺部感染(部分病毒感染及囊性纤维化气道)和肺癌。

关键数值与推荐

  • 多种小分子抑制剂已用于探究 UPR 在疾病模型中的作用,但许多工具具有复杂和脱靶效应。
  • 基于此类药理工具得出的结论可能需要额外证据(如遗传操作)支持。

临床怎么用

  • 认识环境毒素、病原体和缺氧可触发内质网应激与 UPR,关注其在呼吸疾病中的潜在作用。
  • 解读 UPR 小分子抑制剂研究时需警惕脱靶效应,结论需遗传操作等额外证据支持。

局限性

  • 对连接 UPR 与呼吸疾病的情境特异性和疾病特异性机制理解尚不完整。
  • 许多 UPR 小分子工具具有复杂和脱靶效应,药理学证据需额外验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The lungs are exposed to a range of environmental toxins (including cigarette smoke, air pollution, asbestos) and pathogens (bacterial, viral and fungal), and most respiratory diseases are associated with local or systemic hypoxia. All of these adverse factors can trigger endoplasmic reticulum (ER) stress. The ER is a key intracellular site for synthesis of secretory and membrane proteins, regulating their folding, assembly into complexes, transport and degradation. Accumulation of misfolded proteins within the lumen results in ER stress, which activates the unfolded protein response (UPR). Effectors of the UPR temporarily reduce protein synthesis, while enhancing degradation of misfolded proteins and increasing the folding capacity of the ER. If successful, homeostasis is restored and protein synthesis resumes, but if ER stress persists, cell death pathways are activated. ER stress and the resulting UPR occur in a range of pulmonary insults and the outcome plays an important role in many respiratory diseases. The UPR is triggered in the airway of patients with several respiratory diseases and in corresponding experimental models. ER stress has been implicated in the initiation and progression of pulmonary fibrosis, and evidence is accumulating suggesting that ER stress occurs in obstructive lung diseases (particularly in asthma), in pulmonary infections (some viral infections and in the setting of the cystic fibrosis airway) and in lung cancer. While a number of small molecule inhibitors have been used to interrogate the role of the UPR in disease models, many of these tools have complex and off-target effects, hence additional evidence (eg, from genetic manipulation) may be required to support conclusions based on the impact of such pharmacological agents. Aberrant activation of the UPR may be linked to disease pathogenesis and progression, but at present, our understanding of the context-specific and disease-specific mechanisms linking these processes is incomplete. Despite this, the ability of the UPR to defend against ER stress and influence a range of respiratory diseases is becoming increasingly evident, and the UPR is therefore attracting attention as a prospective target for therapeutic intervention strategies.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Bradley KL, Stokes CA, Marciniak SJ, et al. Role of unfolded proteins in lung disease. Thorax. 2020. PMID: 33077618. doi:10.1136/thoraxjnl-2019-213738

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。